Expanding the Spectrum of Mutations in GH1 and GHRHR: Genetic Screening in a Large Cohort of Patients with Congenital Isolated Growth Hormone Deficiency

Author:

Alatzoglou Kyriaki S.1,Turton James P.1,Kelberman Daniel1,Clayton Peter E.2,Mehta Ameeta1,Buchanan Charles3,Aylwin Simon3,Crowne Elisabeth C.4,Christesen Henrik T.5,Hertel Niels T.5,Trainer Peter J.6,Savage Martin O.7,Raza Jamal8,Banerjee Kausik9,Sinha Sunil K.10,Ten Svetlana10,Mushtaq Talat11,Brauner Raja12,Cheetham Timothy D.13,Hindmarsh Peter C.1,Mullis Primus E.14,Dattani Mehul T.1

Affiliation:

1. Developmental Endocrinology Research Group (K.S.A., J.P.T., D.K., A.M., P.C.H., M.T.D.), Clinical and Molecular Genetics Unit, University College London Institute of Child Health, London WC1N 1EH, United Kingdom

2. Endocrine Sciences Research Group (P.E.C.), University of Manchester, Manchester M13 9PL, United Kingdom

3. Departments of Child Health and Endocrinology (C.B., S.A.), King’s College Hospital, London SE5 9RS, United Kingdom

4. Department of Pediatric Diabetes and Endocrinology (E.C.C.), Bristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, Bristol BS2 8BJ, United Kingdom

5. Department of Pediatrics (H.T.C., N.T.H.), H. C. Andersen Children’s Hospital, Odense University Hospital, 5000 Odense, Denmark

6. Department of Endocrinology (P.J.T.), Christie Hospital, Manchester M20 4BX, United Kingdom

7. Department of Pediatric Endocrinology (M.O.S.), William Harvey Research Institute, Barts and The London Queen Mary’s School of Medicine and Dentistry, London EC1M 6BQ, United Kingdom

8. Department of Endocrinology (J.R.), National Institute of Child Health, Karachi, 75510, Pakistan

9. Department of Paediatrics (K.B.), Whipps Cross University Hospital, London E11 1NR, United Kingdom

10. Division of Pediatric Endocrinology (S.K.S., S.T.), Maimonides Infants’ and Children Hospital of Brooklyn and Children’s Hospital of SUNY Downstate, Brooklyn, New York 11203

11. Department of Pediatric Endocrinology (T.M.), Leeds University Teaching Hospitals, Leeds General Infirmary, Leeds LS9 7TF, United Kingdom

12. Department of Pediatric Endocrinology (R.B.), Hôpital Bicêtre, Université Paris Descartes, 75006 Paris, France

13. Institute of Human Genetics (T.D.C.), Newcastle University, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, United Kingdom

14. Pediatric Endocrinology (P.E.M.), University Children’s Hospital Inselspital, CH-3010 Bern, Switzerland

Abstract

Context: It is estimated that 3–30% of cases with isolated GH deficiency (IGHD) have a genetic etiology, with a number of mutations being reported in GH1 and GHRHR. The aim of our study was to genetically characterize a cohort of patients with congenital IGHD and analyze their characteristics. Patients and Methods: A total of 224 patients (190 pedigrees) with IGHD and a eutopic posterior pituitary were screened for mutations in GH1 and GHRHR. To explore the possibility of an association of GH1 abnormalities with multiple pituitary hormone deficiencies, we have screened 62 patients with either multiple pituitary hormone deficiencies (42 pedigrees), or IGHD with an ectopic posterior pituitary (21 pedigrees). Results: Mutations in GH1 and GHRHR were identified in 41 patients from 21 pedigrees (11.1%), with a higher prevalence in familial cases (38.6%). These included previously described and novel mutations in GH1 (C182X, G120V, R178H, IVS3+4nt, a>t) and GHRHR (W273S, R94L, R162W). Autosomal dominant, type II IGHD was the commonest form (52.4%), followed by type IB (42.8%) and type IA (4.8%). Patients with type II IGHD had highly variable phenotypes. There was no difference in the endocrinology or magnetic resonance imaging appearance between patients with and without mutations, although those with mutations presented with more significant growth failure (height, −4.7 ± 1.6 SDS vs. −3.4 ± 1.7 SDS) (P = 0.001). There was no apparent difference between patients with mutations in GH1 and GHRHR. Conclusions: IGHD patients with severe growth failure and a positive family history should be screened for genetic mutations; the evolving endocrinopathy observed in some of these patients suggests the need for long-term follow-up. Results suggest screening for mutations in GH1 and GHRHR in patients of certain ethnic backgrounds with severe growth failure and a positive family history.

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Cited by 95 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3